ARTICLE | Company News
Biogen Idec, Knopp in ALS deal
August 18, 2010 11:09 PM UTC
Knopp Neurosciences Inc. (Pittsburgh, Pa.) granted Biogen Idec Inc. (NASDAQ:BIIB) exclusive, worldwide rights to develop and commercialize dexpramipexole ( KNS-760704). The small modulator of mitochon...